Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,085 | -12,816 | -6,683 | -26,895 | -21,742 |
| Depreciation Amortization | 167 | 116 | 59 | 280 | 218 |
| Accounts payable and accrued liabilities | 469 | -334 | -17 | 514 | 1,354 |
| Other Working Capital | -133 | -229 | -756 | 456 | 1,501 |
| Other Operating Activity | 2,423 | 2,380 | 968 | 3,549 | 1,814 |
| Operating Cash Flow | $-16,159 | $-10,883 | $-6,429 | $-22,096 | $-16,855 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,751 | 3,351 | 3,750 | 3,630 | 4,130 |
| PPE Investments | N/A | N/A | N/A | -14 | -3 |
| Investing Cash Flow | $3,751 | $3,351 | $3,750 | $3,616 | $4,127 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,152 | -1,217 | -301 | N/A | N/A |
| Common Stock Issued | 4,301 | 4,301 | 3,549 | 7,170 | 6,022 |
| Financing Cash Flow | $2,149 | $3,084 | $3,248 | $7,170 | $6,022 |
| Beginning Cash Position | 24,611 | 24,611 | 24,611 | 35,921 | 35,921 |
| End Cash Position | 14,352 | 20,163 | 25,180 | 24,611 | 29,215 |
| Net Cash Flow | $-10,259 | $-4,448 | $569 | $-11,310 | $-6,706 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,159 | -10,883 | -6,429 | -22,096 | -16,855 |
| Capital Expenditure | N/A | N/A | N/A | -14 | -3 |
| Free Cash Flow | -16,159 | -10,883 | -6,429 | -22,110 | -16,858 |